News
Latest valve and structural heart intelligence
Filter by Source
All SourcesAHA Heart NewsCardiovascular BusinessCirculationDiagnostic & Interventional CardiologyHealio Cardiology
Filter by Tag
ACCAHAAbbottAnticoagulationBoston ScientificCMSCongenitalDurabilityESCEdwardsFDAGuidelinesHigh RiskImagingLeafletLow RiskMarketMedtronicMinimally InvasiveRedo-TAVR
Clear filters1 articles tagged CMS
CVB
regulatory·22 days ago·Cardiovascular Business
Cardiologists and surgeons share early feedback after CMS proposed sweeping TAVR changes
CMS proposed significant policy changes affecting TAVR reimbursement and coverage, prompting responses from interventional cardiologists and cardiac surgeons. The clinical and financial implications of these proposed modifications are being evaluated by the structural heart community.
Digest: CMS reimbursement policy directly impacts TAVR program sustainability, patient access, and the economic viability of structural heart programs nationwide.